Stefan Willmann
Stefan Willmann publishes mostly in Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health, on topics such as Pharmacogenetics and Drug Metabolism, Antibiotics Pharmacokinetics and Efficacy and Pharmaceutical studies and practices.
- World rank
- #299,077 of 7,710,434 ranked researchers
- Rank in Germany
- #14,965 of 364,343
- Works
- 117
- Citations
- 5.2k
- Citations per work
- 44.3
What does Stefan Willmann research?
Stefan Willmann's work is mostly in Medicine (28%), Pharmacology, Toxicology and Pharmaceutics (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6555.7%
- Health Sciences3328.1%
- Medicine3328.1%
- Life Sciences1916.2%
- 1Cardiology and Cardiovascular Medicine10% of their works
- 2Pharmacology10% of their works
- 3Pediatrics, Perinatology and Child Health7% of their works
- 4Pharmacology7% of their works
- 5Pharmaceutical Science6% of their works
- 6Hematology5% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical studies and practices
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Drug Solubulity and Delivery Systems
- Statistical Methods in Clinical Trials
- Blood Coagulation and Thrombosis Mechanisms
Which keywords describe Stefan Willmann's research?
The keywords of their largest research topics: Cytochrome P450, Pharmacogenetics, Antithrombotic Therapy, Antibiotic Pharmacokinetics, Critically Ill Patients, Off-Label Drug Use, Pediatric Pharmacokinetics and Anticoagulant Therapy.
- Solid Dispersions
- False Discovery Rate
- Adaptive Designs
- Pulmonary Embolism
- Anticoagulant Therapy
- Off-Label Drug Use
- Antibiotic Pharmacokinetics
- Pharmacogenetics
- Cytochrome P450
- Antithrombotic Therapy
- Critically Ill Patients
- Pediatric Pharmacokinetics
- Atrial Fibrillation
- Venous Thromboembolism
- Cyclodextrins
- Protease-Activated Receptors
- Thrombin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cytochrome P450311 topic
- Pharmacogenetics311 topic
- Antithrombotic Therapy272 topics
- Antibiotic Pharmacokinetics201 topic
- Critically Ill Patients201 topic
- Off-Label Drug Use161 topic
- Pediatric Pharmacokinetics161 topic
- Anticoagulant Therapy141 topic
- Atrial Fibrillation141 topic
- Pulmonary Embolism141 topic
- Venous Thromboembolism141 topic
- Adaptive Designs131 topic
- Cyclodextrins131 topic
- False Discovery Rate131 topic
- Protease-Activated Receptors131 topic
- Solid Dispersions131 topic
- Thrombin131 topic
Where does Stefan Willmann work?
Stefan Willmann's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Stefan Willmann have?
OpenAlex counts 117 works and 5,187 citations for Stefan Willmann, an h-index of 37, ranking #299,077 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stefan Willmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.